What this study is
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women with Inflammatory Bowel Disease study is being conducted at the University of California San Francisco and 30 other sites around the United States who are part of the CCFA Clinical Alliance. The aim of this study is to determine the effect of medication use and disease activity on the outcome of pregnancy among women with IBD up to 18 years from birth.
Study details
- Sponsor
- University of California, San Francisco
- Conditions
- Inflammatory Bowel Disease
- Enrolling
- 1,500 people
- Starts
- 2007-08
- Est. completion
- 2028-06
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 45 YearsSex FEMALEHealthy volunteers Not acceptedYou may qualify if
- Female patients with confirmed IBD diagnoses who are pregnant and taking immunosuppressants and/or biologic therapy
You can't join if
- Pregnant female patients younger than 18 years of age
- Confirmed multiple gestation
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (2)
2 openPlease Contact Jessica Lim For Further Information Regarding Other Sites' Locations
San Francisco, California, United States
RecruitingUniversity of California San Francisco
San Francisco, California, United States
- Jessica Lim · Contact415-885-3734jessica.lim@ucsf.edu
- Uma Mahadevan, MD · Principal investigator
Recruiting
Study team
Sponsor
University of California, San Francisco
Study ID CCFA Pregnancy Registry
Principal investigator
Uma Mahadevan, MD
University of California, San Francisco
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.